William McCombe; Chief Financial Officer; Cytek Biosciences, Inc.

FREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) has introduced an Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ CS system. This is the ...

Interested parties may access a live and archived webcast of these presentations on the “Investors” section of the company website at: investors.cytekbio.com. Cytek’s products are for ...

Cytek Biosciences, Inc. ( (CTKB) ) has released its Q3 earnings. Here is a breakdown of the information Cytek Biosciences, Inc. presented to ...

Cytek Biosciences, Inc. (CTKB) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.01 per share a ...

In recent trading, Cytek Biosciences Inc (CTKB) stock price has shown some volatility, fluctuating 8.96% over the last five trades and -0.58% over the past 30 trades. This represents a notable shift ...

Cytek Biosciences, Inc. (NASDAQ: CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to break-even earnings per share a ...

Short interest in Cytek Biosciences Inc (NASDAQ:CTKB) increased during the last reporting period, rising from 4.30M to 4.47M. This put 4.36% of the company's publicly available shares short.

Millennium Management LLC lifted its position in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 3,452.2% in the second quarter, HoldingsChannel.com reports. The institutional ...

Thank you for standing by. At this time, I'd like to welcome everyone to the Cytek Biosciences' Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any ...